Effect of Actonel on Periodontal Health of Postmenopausal Women

University Hospitals Cleveland Medical Center

Overview

Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.

Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Conditions

Periodontal Disease

Interventions

RisedronateDRUG

Weekly Risedronate

Eligibility

Sex: FEMALEMin age: 40 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Osteopenia * Postmenopausal Exclusion Criteria: * Male * Diabetes

Locations (1)

Uhcmc

Cleveland, Ohio, United States

Outcomes

Primary Outcomes

Periodontal alveolar bone changes

Time frame: one year

Secondary Outcomes

Periodontal attachment levels

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.